BAYTRIL 100 DIN 02249243
Health Canada record
| Active ingredient(s) | ENROFLOXACIN 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 05-Jul-2004 |
| Current status date | 17-Aug-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ENROFLOXACIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02239526 | BAYTRIL | ELANCO CANADA LIMITED | Tablet | ENROFLOXACIN 150 MG | Marketed |
| 02239524 | BAYTRIL | ELANCO CANADA LIMITED | Tablet | ENROFLOXACIN 15 MG | Marketed |
| 02239525 | BAYTRIL | ELANCO CANADA LIMITED | Tablet | ENROFLOXACIN 50 MG | Marketed |
| 02169428 | BAYTRIL INJECTION | ELANCO CANADA LIMITED | Solution | ENROFLOXACIN 50 MG | Marketed |
| 02246715 | BAYTRIL OTIC | ELANCO CANADA LIMITED | Emulsion | ENROFLOXACIN 5 MG; SILVER SULFADIAZINE 10 MG | Marketed |
| 02480891 | ENROTRON 50 | MODERN VETERINARY THERAPEUTICS LLC | Solution | ENROFLOXACIN 50 MG | Marketed |
| 02445662 | FENOFLOX 50 MG/ML SOLUTION FOR INJECTION | CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED | Solution | ENROFLOXACIN 50 MG | Approved |
| 02169444 | BAYTRIL | ELANCO CANADA LIMITED | Tablet | ENROFLOXACIN 22.7 MG | Dormant |
| 02169452 | BAYTRIL | ELANCO CANADA LIMITED | Tablet | ENROFLOXACIN 68 MG | Dormant |
| 00812285 | BAYTRIL INJ 22.7MG/ML | BAYVET, DIVISION OF CHEMAGRO LTD. | Liquid | ENROFLOXACIN 22.7 MG | Cancelled Post Market |
| 01923781 | BAYTRIL INJ 50MG/ML | BAYVET, DIVISION OF CHEMAGRO LTD. | Liquid | ENROFLOXACIN 50 MG | Cancelled Post Market |
| 02142236 | BAYTRIL INJECTION - LIQ IM 50MG/ML | MILES CANADA INC. - AGRIC., DIVISION OF ANIMAL HEALTH | Liquid | ENROFLOXACIN 50 MG | Cancelled Post Market |
| 00719773 | BAYTRIL TABLETS 22.7MG | BAYVET, DIVISION OF CHEMAGRO LTD. | Tablet | ENROFLOXACIN 22.7 MG | Cancelled Post Market |
| 00719765 | BAYTRIL TABLETS 5.7MG | BAYVET, DIVISION OF CHEMAGRO LTD. | Tablet | ENROFLOXACIN 5.7 MG | Cancelled Post Market |
| 00719781 | BAYTRIL TABLETS 68MG | BAYVET, DIVISION OF CHEMAGRO LTD. | Tablet | ENROFLOXACIN 68 MG | Cancelled Post Market |
| 00719757 | BAYTRIL TURKEY EGG DIP CONCENTR 32.3MG | BAYVET, DIVISION OF CHEMAGRO LTD. | Liquid | ENROFLOXACIN 32.3 MG | Cancelled Post Market |
| 02169460 | BAYTRIL TURKEY EGG DIP CONCENTRATE-32.3MG/ML | BAYER INC., ANIMAL HEALTH | Liquid | ENROFLOXACIN 32.3 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24755 | 2020-12-07 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 13212 | 2012-04-23 | Supplement to a New Drug Submission (SNDS) | New indications |
| 3633 | 2004-02-12 | New Drug Submission (NDS) |
International API supply for ENROFLOXACIN
2 active FDA Drug Master Files.
Request a quote for BAYTRIL 100